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Abstract 
Mental health inpatients’ self-reported violence risk predicts actual aggressive outcomes. 
Anger, for which there are well-evidenced interventions, commonly precedes inpatient 
aggression. We aimed to determine whether patients’ self-reported anger added incremental 
validity to violence prediction beyond routinely completed violence risk assessments. A 
correlational, pseudo-prospective study design was employed. N=76 inpatients in secure 
hospitals completed self-report validated anger measures; routinely collected clinicians' 
ratings on structured professional judgement tools, and aggressive incident data for a 3-month 
follow-up period were extracted from clinical records. Thirty four (45%) participants were 
violent; self-reported-anger and clinician-risk ratings were significantly positively correlated. 
Self-reported anger predicted aggressive outcomes but not incrementally beyond relevant risk 
assessment subscale and item scores. It may not be beneficial for all patients to self-report 
anger as part of continuous violence risk assessments, but those who score highly on anger-
relevant items of risk assessment tools could be considered for further assessment to support 
risk-management interventions. 
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Introduction 
Aggressive patient behaviour on psychiatric wards is common (Bowers et al., 2011) 
and the psychological, emotional and financial consequences are substantial (Flood, Bowers, 
Parkin, 2008; Rippon, 2000; Uppal & McMurran, 2009; Wykes & Whittington, 1998). 
Typically, violence risk assessments are completed by clinicians to aid formulations about the 
likelihood and nature of risk, its management and treatment for the duration of patients’ 
hospitalisation and following discharge or transfer.  Violence risk assessment tools, including 
for inpatient use, commonly comprise organised schedules of known risk factors, each of 
whose presence and relevance clinicians are required to consider. In the structured judgement 
approach, the outcome of this exercise is integrated with clinical expertise and case-specific 
knowledge to devise a formulation about the likelihood, nature, and circumstances of future 
aggressive behaviour.  
The Historical-Clinical-Risk-Management 20 (HCR-20; Webster, Douglas, Eaves & 
Hart, 1997) is the most commonly used tool in forensic mental health settings (Khiroya, 
Weaver & Maden, 2009). It contains both static (i.e., historical) and dynamic risk factor 
items. Studies have shown that the HCR-20 has good predictive validity for inpatient 
aggression. A systematic review (O’Shea, Mitchell, Picchioni & Dickens, 2013) involving 
2,067 patients across 20 studies found that the summary judgment (i.e., Low, Moderate, 
High) of risk was a stronger predictor of inpatient aggression than any of the HCR-20 
subscales. Although this finding is promising, as it is the approach advocated by the tools’ 
authors to derive a judgement of overall risk level, it has been criticised for its limited ability 
to inform day-to-day treatment and management of risk factors (Ogloff & Daffern, 2006; 
Ireland et al., 2016). A second tool, the Short-Term Assessment of Risk and Treatability 
(START; Webster, Martin, Brink, Nicholls & Desmarais, 2009), comprises 20 dynamic risk 
factor items. Its use is intended to aid risk prediction in the shorter-term (three months) and 
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for a range of adverse outcomes in addition to violence. The dynamic items are to be 
considered in terms of both strengths (protective factors) and vulnerabilities (risk factors) 
which sets the START apart from other SPJ tools (Nonstad et al., 2011).  
Despite advances in risk assessment research, the current evidence base has lagged in 
terms of management interventions. This may partly be because frontline staff members, such 
as nurses and healthcare assistants who take a hands-on approach in the delivery of care 
plans, are perhaps not always involved in the completion of violence risk assessment process 
or relevant risk information is not sufficiently communicated (Bruton, Norton, Smyth, Ward 
& Day, 2016; Eivergard, Enmarker & Hellzen, 2016). The question of whether SPJ tools are 
effective and efficient in respect of risk management requires further exploration. A greater 
understanding of the identification and assessment of relevant dynamic risk factors allied 
with further research into relevant treatment interventions would be a good first step. 
Anger is a well-established antecedent of inpatient aggression (Bowers et al., 2011; 
Daffern & Howells, 2009) and has been shown to be one of the strongest predictors of 
violence (Doyle & Dolan, 2006; McDermott, Edens, Quanbeck, Busse & Scott, 2008; 
McDermott, Quanbeck, Busse, Yastro & Scott, 2008; Vitacco et al., 2009). The provision for 
assessment and treatment of anger, compared with that for depression and anxiety, has lagged 
in mental health care (DiGiuseppe & Tafrate, 2007). Anger has often, incorrectly, been 
perceived as a behavioural manifestation of psychotic symptomatology rather than of 
dysregulated emotion warranting of clinical attention (Novaco, 2010). This may partly 
explain the relative neglect of direct assessment and treatment of anger in the context of 
inpatient aggression, despite evidence indicating that anger management programmes in 
hospital settings are effective in reducing aggression (Jones & Hollin, 2004; Renwick, Black, 
Ramm & Novaco, 1997; Wilson et al., 2013).  
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Further, anger is not specifically named as a risk factor item in either the HCR-20 or 
the START. The omission is perhaps understandable since items in both tools are broader and 
encapsulate anger amongst a range of other dispositions/presentations. For example, in the 
START, anger is identified as one of eleven descriptors (‘angry’) for the item Emotional 
State (others include ‘pessimistic’, ‘lethargic’, and ‘emotionally restricted). In addition, 
potential anger synonym terms ‘hostile’ and ‘aggressive attributional style’ are included 
among 15 descriptors for the Attitudes item (Webster et al., 2009). In the HCR-20, elements 
of the anger construct appear to be embedded in three of the Clinical subscale items: in the 
description of the Lack of Insight item, raters are advised to ‘determine the extent to which 
the person perceives himself or herself to be dangerous, angry, or out of control’; for the 
Impulsivity item that ‘behavioural and affective instability’ be considered; and, for the 
Unresponsive to Treatment item, that attention should be given to ‘whether the individual has 
recently been placed in seclusion and for what reasons, and whether there have been 
occurrences of angry outbursts and rage episodes’ (Webster et al., 1997).  
The responsibility for gauging the presence and relevance of anger in violence risk 
assessment using these tools lies with the evaluator(s); they are advised to consult a range of 
available sources including clinical notes, clinical interview with, and observations of, the 
individual. While the assessment might be informed by formal, validated assessments of 
anger, where they are present, there is no requirement for raters to undertake any systematic 
measurement of anger. DiGuiseppe and Tafrate (2007) define anger as multidimensional to 
include physiological, cognitive and behavioural aspects which can manifest as state or trait 
characteristics. As described above, the assessment of anger in the HCR-20 and the START 
form part of a global evaluation and thus, presumably, may rely more on raters’ confidence 
and ability to detect its presence and relevance than on any objectively determined criteria. 
However, Desmarais, Nicholls, Read and Brink (2010) have reported that the judgements of 
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evaluators who had higher confidence in their ratings on an SPJ tool were actually associated 
with lower predictive accuracy for risk outcomes.  
In relation to anger, this leads to two important questions.  First, is patients’ self-
reported anger associated with clinicians’ ratings on respective items in routinely completed 
violence risk assessments: i.e., do relevant items accurately reflect the content of validated 
anger assessments? Second, does self-reported anger on a validated measure increase risk 
prediction incrementally over that achieved by the tools’ more globally-oriented items. This 
is important not only for risk assessment but also with regard to the recommendation of 
appropriate treatment interventions. In brief, could a more objective approach to evaluation of 
the presence of anger inform violence risk assessment and risk management planning? The 
aim of the present study, therefore, is to examine associations between patients’ self-reported 
anger and clinicians’ ratings on relevant dynamic risk factor items from the HCR-20 and the 
START, and subsequently to examine whether self-reported anger adds incrementally to the 
predictions of inpatient aggression. 
Methods 
Setting and Participants 
The present study was conducted on medium and low-secure wards constituting the 
men’s and women’s adult mental disorder pathways at St Andrew’s Healthcare, a United 
Kingdom provider of specialist mental health care. Relevant wards are located in 
Northampton, Birmingham, and Essex. Each wards’ responsible clinician identified patients 
from their caseload based on the inclusion criteria for potential participation and were 
subsequently approached to provide further study information. Eligible participants were 
inpatients over the age of 18 years, diagnosed with one or more mental disorder based on the 
World Health Organisation (2011) International Classification of Diseases and Related 
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Health Problems 10th Revision (ICD-10), and who had been subject to two of the routinely 
completed Structured Professional Judgement (SPJ) assessments, HCR-20 and START, prior 
to participation. Patients were not eligible if they had a diagnosis of a neurocognitive or 
neurodevelopmental disorder, lacked the capacity to consent, or were not fluent in the 
English language.   
Design  
Manuals for both HCR-20 and START were carefully considered in order to identify 
how the concept of anger was operationalised and defined within them, followed by detailed 
discussions between the authors and clinicians. A correlational and pseudo-prospective 
cohort design was employed to test: i) the hypothesised relationships between patients’ self-
reported anger and clinician-rated items in the SPJ tools; and ii) whether the self-reported 
anger added incremental validity in the prediction of aggressive behaviour over a 3-month 
follow-up period.  
Procedure 
The study was one part of a doctoral thesis by author RJ which received approval 
from the University of Northampton Research Ethics Committee, the Leicestershire, 
Northamptonshire and Rutland NHS Research Ethics Committee (Reference: 13/EM/0020. 
IRAS ID: 120833), and the St Andrew’s Healthcare Research and Development Committee. 
Patients were recruited between April 2013 and May 2015. The SPJ assessments used in the 
study were completed by multidisciplinary teams as part of routine practice in the same 
period; patients provided their consent for the researchers to access these assessments as part 
of the study.  All eligible patients were approached with the study information sheet. Only 
those expressing interest and, subsequently on being given full information, consent, were 
then enrolled in the study and interviewed. The study questionnaire (see below) was 
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completed during the pre-arranged interview conducted by author RJ (forensic psychology 
masters’ graduate and doctoral student) in a quiet room on the ward. Data concerning 
aggressive behaviour were retrieved from relevant electronic patient records over a three 
month duration following participation. This follow-up period was judged appropriate for the 
study given that the START is recommended to be completed every three months (Webster et 
al., 2009; Dickens & O'Shea, 2015), or sooner if there is reason to suspect a change in the 
patients’ risk profile.  
Measures 
Novaco Anger Scale (Novaco, 2003) 
The Novaco Anger Scale is a 60-item measure comprising four subscales, each 
addressing an aspect of anger disposition related to: Cognition, Arousal, Behaviour, and 
Regulation. The response format for each item is a 3-point unipolar visual analogue scale (1 = 
Never True, 2 = Sometimes True, and 3 = Always True) and scoring produces subscale scores 
and a total score based on 48 items across the Cognition, Arousal and Behaviour subscales. 
The Inconsistency Reporting Index is a check as part of the scoring method that is based on 
16 selected item-pairs, to eliminate random or deliberately inconsistent reporting which is 
indicated by a large number of dissimilarities between item-pair scores. The measure was 
developed for use with various populations, including clinical forensic patients, and has been 
found to have good reliability including for the current sample (Cronbach’s alpha .94) and 
excellent construct and concurrent validity (Novaco, 2003). 
Historical Clinical Risk-management – 20 Version 2 (Webster, Douglas, Eaves & Hart, 
1997)  
The Historical Clinical Risk-management – 20 (HCR-20) is a comprehensive set of 
professional guidelines for the assessment and management of risk factors for violent 
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behaviour. The tool consists of 20 items which are organised under headings i) Historical 
(10-items about the past); ii) Clinical (5 items about current clinical presentation) and iii) 
Risk management (5 items about adjustment under changing future circumstances).The 
coding is completed on two levels; evaluators must first determine the presence versus 
absence for each of the 20 items (0 = No - The item is absent or does not apply, 1 = Maybe – 
The item possibly is present, or is present to a limited extent,  2 = Yes – The item is definitely 
present, Omit = Don’t know – There is insufficient valid information to permit a decision 
concerning the presence or absence of the item); second, the item-level information is 
integrated with all other relevant information to reach a summary judgement for future 
violence risk (Low, Moderate, or High). Multiple sources of information are recommended 
for use in completing the coding of the risk assessment including file review, interview and 
testing. At the time of this study, version 2 of the HCR-20 was being used as version 3 had 
not yet been implemented in the hospital. The HCR-20 was completed as part of routine 
clinical practice by registered psychologists or assistant psychologists under their 
supervision, and ratified by the clinical team. For the purposes of research, the HCR-20 is 
used in an actuarial manner (Campbell, French & Gendreau, 2009; Singh, Grann & Fazel, 
2011); that is by summing individual item ratings to derive a total score that can range from 0 
to 10 for each dynamic risk scale (HCR-20 Clinical Total and HCR-20 Risk-management 
Total) and 0 to 20 for the Historical scale. The dynamic risk subscales only were used for the 
purposes of this study. In the HCR-20 manual (Webster et al., 1997), item descriptions for 
Lack of Insight (C1), Impulsivity (C4) and Unresponsive to Treatment (C5) recommend that 
evaluators consider anger. Thus, clinicians’ ratings of C1, C4 and C5 were examined to test 
the association with patients’ self-reported anger. The average mean number of days between 
administration of the HCR-20 and study participation was 80.8 (SD = 44.5). 
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Short-Term Assessment of Risk and Treatability (Webster, Martin, Brink, Nicholls & 
Desmarais, 2009) 
The Short-Term Assessment of Risk and Treatability is an assessment for multiple 
risk behaviours: violence, suicide, self-harm, victimization, substance use, unauthorised 
absences and self-neglect. For each behaviour, the evaluating team is required to estimate the 
level of risk (Low, Moderate, or High) following the rating of the scheme's 20 dynamic risk 
items and consideration of other relevant factors. Ratings are made for each item in relation 
to strengths (0 to 2) and vulnerabilities (0 to 2). Vulnerabilities comprise features or 
characteristics that are likely to be associated with increased likelihood of adverse outcomes, 
whereas Strengths are positive attributes that serve as a resource to reduce, mitigate and 
manage the likelihood of adverse outcomes. The START was completed as part of routine 
clinical practice by trained members of the clinical team. In the study setting, it is required 
that the completed START for each patient is signed off by three members of the clinical 
team from different professions (psychiatrist, psychologist, nurse, occupational therapist, 
social work). In the START manual, descriptions for vulnerability on the items Emotional 
State and Attitudes refer to the construct of anger. As a result, clinicians’ ratings of these 
items were thus used in this study to test the association with patients’ self-reported anger. 
Clinicians’ ratings on all the strength and vulnerability items were summed for a ‘START 
total strength’ and ‘START total vulnerability’ score (both possible range 0-40) and were 
also used for the purpose of this study. The average mean number of days between 
administration of the START and study participation was 47.1 (SD = 34.8). 
Overt Aggression Scale (Yudofsky, Silver, Jackson, Endicott & Williams, 1986) 
The Overt Aggression Scale (OAS) aims to capture information about the frequency 
and severity of four categories of aggressive behaviour (verbal, physical against objects, self 
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or others). The OAS was used to rate incidents which had been recorded on RiO, the 
electronic recording system used in the study setting. Clinical staff members are expected to 
make at least one narrative entry regarding the patient on RiO per shift, as dictated by the 
hospital policy directive. Before the note can be verified, the staff member is prompted to add 
one or more ‘flags’ to the entry. Thus the entire notes regarding the patient can be searched 
by filters such as flags, dates, times, etc. Case notes that were electronically flagged as either: 
‘Aggression – Physical’, ‘Aggression – Verbal’, ‘Fire setting’, ‘Hostage Taking’, 
‘Intimidation/Bullying’, ‘Self-Harm/Suicide’, and “Sexual Offending” and that had occurred 
in the follow-up period were obtained for all patient participants. Each incident was coded 
against the categories in the OAS by the authors and who were blind to the predictive 
measure assessments. Inter-rater reliability was tested on all identified incidents and 
categorical agreement on aggression type was in the substantial range (K = 0.74). To reduce 
the number of aggression types analysed, aggressive outcomes were amalgamated into two 
dichotomised (absent/present) categories: any aggression (‘any aggression’; included verbal 
aggression, physical aggression towards objects, self and others) and physical aggression 
towards others (‘physical aggression’).   
Clinical and Demographic Characteristics 
Patients’ gender, age, self-reported ethnicity, admission/discharge date (length of 
stay), ward security level and ICD-10 diagnoses were extracted from clinical records. Also, a 
registered psychologist from each clinical team completed the Clinical Global Inventory-
Severity (CGI-S; Busner & Targum, 2007). The CGI-S provides an overall clinician-
determined summary measure of mental illness that takes into account all available 
information, including knowledge of the patient’s history, psychosocial circumstances, 
symptoms, behaviour, and the impact of the symptoms on the patient’s ability to function. In 
practice, the CGI-S captures the overall clinical impression of the patient. It is a 1-item 
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measure that asks the respondent the following question: “Considering your total clinical 
experience with this particular population, how mentally ill is the patient at this time?” 
Ratings for the severity of the patients’ presenting illness is indicated on a 7-point scale (1 = 
Normal, not at all ill, 2 = Borderline mentally ill, 3 = Mildly ill, 4 = Moderately ill, 5 = 
Markedly ill, 6 = Severely ill, 7 = Among the most extremely ill patients). As symptoms can 
fluctuate over a week; the score reflects the average severity level across the previous seven 
days.   
Data Analysis 
Initially, data were subjected to normality testing using the Shapiro-Wilk test in 
conjunction with inspection of histograms, kurtosis and skewness values as recommended by 
Field (2013); bootstrapping was applied where assumptions of normality were violated. 
Bootstrapping is a robust method to correct for bias by resampling with replacement and 
provides confidence intervals for a statistical parameter including the mean, odds ratio, 
correlation and regression coefficients (Field, 2013).  
Means and standard deviations for scale variables and frequencies/percentages for 
categorical variables measured in the study were calculated. Independent t-tests were used to 
ascertain any differences in self-reported anger and dynamic risk item and subscale scores 
between aggressive outcomes (any aggression and physical aggression only). The magnitude 
of difference in scores was denoted by the t-value converted into an r-value (Rosnow & 
Rosenthal, 2005) for an effect size, with the following thresholds: small (.20), medium (.30) 
and large (.50). Pearson’s correlation was used to explore the relationship between patients’ 
self-reported anger and clinicians’ ratings on anger-related items in the dynamic risk 
subscales. Receiver operating characteristic (ROC) analyses was used to calculate Area 
Under the Curve (AUC) for the predictive validity of variables on any aggression and 
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physical aggression-only as the outcome. The AUC value ranges from 0 (perfect negative 
prediction) to 1 (perfect positive prediction), with .5 representing performance of the measure 
being equivalent to chance. Although there is some variation in the literature (Singh, 
Desmarais & Van Dorn, 2013) for thresholds in indicators of performance, Rice and Harris 
(2005) report that AUC values of .556, .638, and .714 respectively are equivalent to small 
(.2), moderate (.5) and large (.8) Cohen’s d values (Cohen, 1992). To ascertain incremental 
predictive validity of self-reported anger, a hierarchal logistic regression test was used.  Only 
the statistically significant dynamic risk subscale predictor(s), as determined by the ROC 
analyses, were entered first into the regression model, followed by self-reported anger in the 
second step of the model. The reverse entering of predictor variables in the steps of the model 
was also conducted. Incremental validity is thus indicated by significant changes in the chi-
squared values in improvement between the two steps in the hierarchal logistic regression 
model (Field, 2013). Analyses were conducted using IBM Statistics version 22 for Windows 
(SPSS Inc., Version 22).  
Results 
Participant Clinical and Demographic Characteristics 
In total, 76 patients (50% male) were recruited into the study (see Table 1). 
Participants had been resident on inpatient wards for a mean of 2.9 years (SD = 2.8) and were 
considered ‘moderately ill’ (M = 3.8, SD = 1.5) in terms of severity of presenting problems as 
indicated on the CGI. There were 238 recorded aggressive incidents. More males than 
females exhibited aggression: of those who exhibited any form of aggressive behaviour 65% 
were male, and of those who exhibited physical aggression 62% were male. Analysis of 
potential covariates between the predictive measures revealed that, apart from HCR-20 
scores, females had significantly higher NAS Total and START Vulnerability scores; there 
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were no significant differences on participant ethnicity, diagnosis or the ward security level in 
which the participant resided. 
>>Insert Table 1 about here<< 
Association between patients’ self-reported anger score and clinician-rated SPJ anger-
related item scores, and between aggressive outcomes 
Scale scores for patients’ self-reported anger (NAS Total) and clinician-rated items on 
the dynamic subscale between aggressive outcomes are presented in Table 2. For the category  
'any aggression', analysis revealed significant differences in mean scores for both of the 
HCR-20 dynamic risk subscales, as well as the HCR-20 C5 and the START Emotional State 
items. For physical aggression only, analysis revealed differences in mean score for the NAS 
Total, two of the HCR-20 Clinical items, the HCR-20 Clinical Total subscale and the START 
Strength Total subscale. Statistical differences were indicated with a small to medium effect 
size in both aggressive outcomes. 
>> Insert Table 2 about here<< 
Correlational analyses revealed associations between patients’ self-reported anger and 
dynamic risk item ratings and total subscale scores in expected directions (see Table 3). The 
strongest, positive association was between NAS Total and HCR-20 Clinical Total subscale, 
followed by HCR-20 Impulsivity (C4).  
>> Insert Table 3 about here<< 
Predictive and Incremental Validity  
The AUC values (see Table 4) indicated that NAS Total, HCR-20 Clinical Total and 
HCR-20 Risk-management Total has significant medium to large predictive validity for any 
aggression. The remaining variables did not predict this outcome with statistical significance. 
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For physical aggression-only, the AUC values revealed that NAS Total, HCR-20 Clinical 
Total and START Strengths Total were also significantly predicted with medium to large 
effect sizes, but not HCR-20 Risk-Management total and START Vulnerabilities Total. 
>> Insert Table 4 about here<< 
Statistically significant dynamic risk subscale scores as identified by AUC values 
were block entered into the first model of the hierarchical logistic regression, along with 
patients’ self-reported anger in the second model, for both aggressive outcomes (see Table 5).  
For any aggression, model 1 (HCR-20 Clinical Total and HCR-20 Risk-Management 
Total) was statistically significant χ² = 12.88, p<.01. The model explained 21% of the 
variance and correctly classified 70% of cases. Sensitivity was 64.7%, specificity was 73.8%, 
positive predictive value was 66.7% and negative predictive value was 72.1%. Of the two 
predictor variables, only HCR-20 Clinical Total was statistically significant. Increasing HCR-
20 Clinical Total scores is associated with aggression (OR 1.38). Model 2 (HCR-20 Clinical 
Total, HCR-20 Risk-Management Total and NAS Total) was also statistically significant χ² = 
13.00, p<.01. The difference (0.12) between Model 1 and Model 2 was not statistically 
significant thus indicating that there was no incremental validity of self-reported anger 
present. Linearity of the logit was also tested which revealed that interaction terms were not 
significant p>.05, and thus did not violate the assumption. Collinearity diagnostics confirmed 
that there were no concerns with multicollinearity (VIF = 1.34, Tolerance = 0.75). 
For physical aggression only, model 1 (HCR-20 Clinical Total and START Strengths 
Total) was statistically significant χ² = 15.15, p<.01. The model explained 30% of the 
variance and correctly classified 83% of cases. Sensitivity was 15.4%, specificity was 97%, 
positive predictive value was 50% and negative predictive value was 85%. Of the two 
predictor variables, only the HCR-20 Clinical Total was statistically significant. Increasing 
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HCR-20 Clinical Total scores was associated with physical aggression (OR 1.82). Model 2 
(HCR-20 Clinical Total, START Strengths Total and NAS Total) was also statistically 
significant χ² = 16.81, p<.01. The difference (1.66) between Model 1 and Model 2 was not 
statistically significant thus indicating that there was no incremental validity of self-reported 
anger present. Linearity of the logit was also tested which revealed that interaction terms 
were not significant p>.05, and thus did not violate the assumption. Collinearity diagnostics 
confirm that there were no concerns with multicollinearity (VIF = 1.43, Tolerance = 0.70). 
>> Insert Table 5 about here<< 
Discussion 
In the current study, we examined the role of anger in inpatient aggression and its role 
for risk assessment for aggression. The hypothesis that patients’ self-reported anger would be 
related to clinicians’ ratings on selected items of routinely recorded risk assessment schedules 
is supported by the current findings. The strongest association was between items in the 
Clinical subscale of the HCR-20 and anger, namely: Impulsivity (C4), Lack of Insight (C1) 
and Unresponsive to Treatment (C5) in that order. The START Emotional State and Attitude 
items were also significantly positively related to patients’ self-reported anger, which could 
also suggest that anger-related descriptor items are being correctly interpreted by raters and 
incorporated into item rating. Additionally, ROC analyses indicated that patients’ self-
reported anger was itself significantly predictive of both aggressive outcomes, namely any 
aggression and physical aggression-only. Different combinations of clinician-rated HCR-20 
dynamic risk subscale items were found to be predictive of any aggression and physical 
aggression-only, but the tool’s Clinical total score consistently predicted both outcomes. 
However, a hierarchal logistic regression model did not indicate incremental validity for 
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patients’ self-reported anger, in either aggressive outcome, and HCR-20 Clinical Total 
remained the significant predictor variable.    
These findings are, to some extent, consistent with previous research carried out by 
Doyle and Dolan (2006). Using comparable sample sizes and outcomes, both studies revealed 
similar baselines rates of aggression, similar AUC values for anger in the prediction of any 
aggression, and increased AUC values for anger for the prediction of physical aggression-
only. The current study adds value by extending the findings to a sample comprising equal 
numbers of men and women, whereas Doyle and Dolans’s work was conducted with a male-
dominated sample. The failure of measured anger to incrementally predict aggressive 
outcomes could be explained by the suggestion that anger is neither necessary nor sufficient 
for aggression to occur (Novaco, 1986). Indeed, this may be axiomatic with regard to 
instrumental aggression; however, in the case of reactive aggression anger may be a key 
variable.  In one study that did attempt to discriminate between reactive and instrumental 
physical aggression, McDermott, Quanbeck, et al. (2008) found that HCR-20 dynamic risk 
subscales had higher AUC values than the NAS for the prediction of reactive aggression. The 
authors reported AUC values from .70 to .71 for the Clinical and Risk-management 
subscales, and .67 for anger in the prediction of reactive aggression. It should, however, be 
noted that it has been notoriously difficult for researchers to successfully operationalise 
definitions, and subsequently accurately distinguish individual incidents, of aggression based 
on their cognitive (intent, motivation) or affective (emotional drivers) characteristics and 
these findings require replication (e.g., Bowers, Nijman & Palmstierna, 2007). 
In the current study AUC values for the respective dynamic risk subscales fared 
slightly better, ranging from .66 to .81, and .75 for anger in the prediction of physical 
aggression. However, analysis revealed no incremental validity for self-reported patient anger 
over clinicians’ rating on the dynamic subscales, for the prediction of any aggression or 
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physical aggression. Rather the clinician-rated HCR-20 Clinical subscale was the significant 
predictor. The HCR-20 Clinical subscale considers a range of current risk factors that 
contributes to patient’s risk state for the likelihood of aggression, and anger may indeed be 
relevant but only in combination with other salient dynamic risk factors. One possible 
explanation is that raters are already accurately determining the extent and nature of the 
contribution of anger to individual violence risk within the rating of the relevant dynamic risk 
scale items and that more accurate consideration, e.g. through use of the NAS, is simply 
failing to contribute further. It is, however, noteworthy that the mean anger scores 93.6 – 
101.1 as found in the current study for those that were aggressive are higher than the 
standardisation sample (83.9) for the NAS (Novaco, 2003), and previous studies (e.g., Doyle 
& Dolan, 2006; McDermott, Quanbeck, et al., 2008) using forensic samples (78.7 - 82.0) 
which seems conspicuously low. Nonetheless, if this is the case then it suggests that those 
rated at elevated risk for those items could be targeted for individual assessment of their 
anger. Indeed this is also supported by higher scores on relevant assessment items for 
aggressive over non-aggressive patients in the current study.  
Nevertheless, the current findings add to our understanding of relationships between 
patient self-rated clinical measures and clinician-ratings of dynamic risk factors items on 
structured professional judgement tools. The relevance of anger is demonstrated by positive 
correlations between its self-report and clinicians’ ratings of the items in the dynamic risk 
subscales. Increase in anger scores was associated with higher ratings on the dynamic risk 
items included in the subscales. This concurring view suggests that interventions directed at 
addressing anger dysregulation could help to minimise inpatient aggression risk. Evaluations 
of anger dysregulation interventions in high secure hospital settings (Wilson et al., 2013), 
correctional settings (Tew, Dixon, Harkin & Bennett, 2012) and among patients with 
intellectual disabilities in secure settings (Novaco & Taylor, 2015) have indicated a resulting 
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reduction in physical assaults. Further, given that risk assessments in the current study were 
conducted as part of routine clinical practice, the evidence that clinicians’ risk ratings on 
relevant items corresponded with patients’ self-reported anger should provide some 
confidence about the former’s judgement.  
Limitations 
As with other studies that attempt to establish the predictive validity of risk 
assessments for inpatient aggression, it should be recognised that the clinical staff involved in 
the scoring of the SPJ tools in this study were also those operationalising a risk management 
plan which may have prevented incidents of inpatient aggression (Doyle & Logan, 2012). 
Thus, this may have impacted on the accuracy of the measures included in this study. 
However, data relating to the three-month reported aggressive incidents may be an 
insufficiently long follow-up period but were coded independently and blind to the predictive 
measures. It is also important to bear in mind that whilst it is advantageous to use clinicians’ 
rating of the dynamic items in routine clinical practice to increase the ecological validity of 
findings, not all patients would have had this completed at the same time or proximally 
within the time of the self-reported anger assessment. In this study, the most recent SPJ 
assessment prior to the assessment of anger was retrieved, but it is possible that some patients 
were due another SPJ risk assessment as it is recommended to be completed every three 
months, or when there is a significant change in risk. A further study limitation concerns 
aggression and patient gender. These categorical variables are unsuitable for mediation 
analysis and we were thus unable to determine whether gender mediates the relationship 
between self-reported anger and aggression. However, gender was not revealed as a covariate 
in the logistic regression analysis. Other clinical and demographic characteristics were not 
revealed as potential covariates however; diagnosis variable consisted of either personality 
disorder, schizophrenia spectrum disorder or bipolar and related disorder categories which 
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can constitute variation within these broad ICD-10 codes. A future experimental study could 
involve a pre-and post-test with an anger treatment intervention. This would allow 
researchers and clinicians to establish whether there has been a reduction in scores in 
dynamic risk subscales on the SPJ tools and on an anger measure in the post assessment. But 
also, more importantly, whether there has been a reduction in inpatient aggression incidents 
following a targeted treatment intervention.  
Clinical implications 
An implication of this study is that patients self-reporting as part of the assessment for 
violent-risk, particularly on dynamic risk factors, should be encouraged where possible. In 
this study, patients only parted with information relating to anger as one risk factor which 
may or may not manifest in aggressive incidents. The main purpose of the NAS, as an anger 
assessment instrument, is to aid clinical case formulation for targeting treatment (Novaco, 
2003) and studies have indeed found a reduction in assaults (Novaco & Taylor, 2015; Tew et 
al., 2012; Wilson et al., 2012). Other characteristics that may play a role in inpatient 
aggression, which have an identifiable treatment intervention, should also be sought from 
patients and included in the risk assessment and management plans. As advocated by Tait and 
Lester (2005), patient involvement in this manner could potentially even be therapeutic for 
the patient and in turn increase insight into the factors responsible for their aggressive 
behaviour. It could also help guide clinicians’ decisions more effectively in the SPJ scheme 
in terms of the risk-level posed and for the identification of targeted treatment, for which 
progress could be monitored more closely and collaboratively with patients. 
Conclusion  
This study set out to determine whether there is any value in patients’ self-reported 
anger in addition to clinical routine assessment of inpatient aggression-risk using SPJ tools, 
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such as the HCR-20 and START dynamic risk subscales. As dynamic risk factors are 
amenable to change through intervention, anger as one of many dynamic risk factors relevant 
to inpatient aggression should be addressed in terms of treatment. Although self-reported 
anger did not add incremental validity over clinician-rated risk factors in the prediction of 
inpatient aggression, in the interest of limited resources it may not be ideal to administer 
another assessment for this purpose. Items in the SPJ tools relating to the global evaluation of 
anger seem to adequately capture its association for inpatient aggression. Patients who score 
highly on anger-relevant items in the SPJ tools, might be prioritised for further anger-related 
assessment. The positive relationship between patients’ self-reported anger and clinician-
rated items in the dynamic risk subscales suggests targeted treatment interventions for anger 
could potentially reduce level of risk. It would thus be good practice to consider patient 
involvement where possible in violence-risk assessments for better informed risk 
management plans. This may facilitate increased self-awareness and insight into their unique 
set of risk factors, and in turn, become more compliant to engage in relevant treatment 
interventions to address and reduce their level of risk.  
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Table 1. Participant demographics and characteristics 
Characteristics of patient participants (N=76) n (%) 
Gender  
 Female 38 (50.0) 
 Male 38 (50.0) 
Ethnicity:  
 Caucasian 52 (68.4) 
 Black 16 (21.1) 
 Asian 8 (10.5) 
Primary diagnosis:  
 Personality disorder 39 (51.3) 
 Schizophrenia spectrum disorder 32 (42.1) 
Bipolar and related disorder 5 (6.6) 
Security Level resided on:  
 Low secure 51 (67) 
 Medium secure 25 (33) 
Exhibited aggressive behaviour:  
 Any aggression 34 (45.0) 
 Physical aggression 13 (17.0) 
Age years (Mean [SD]) 34.0 [11.6] 
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Table 2. Independent samples t-tests of patient and clinician-rated differences on anger between 
exhibited/ not exhibited aggressive behaviours 
 Aggressive outcomes    
 Any aggression    
 Aggression (n=34) No aggression (n=42)    
 M (SD) 95% CI M (SD) 95% CI t (df) P r 
NAS Total 93.6 (16.5) 88.4, 99.0 86.8 
(14.9) 
82.2, 91.4 -1.89(74) .06 0.22 
HCR-20 Clinical Total 6.7 (2.1) 5.9, 7.3 4.9 (2.2) 4.2, 5.6 -3.52(74) .00 0.38 
C1 1.6 (0.6) 1.4, 1.8 1.3 (0.6) 1.1, 1.5 -1.85(74) .07 0.20 
 C4 1.4 (0.7) 1.2, 1.7 1.2 (0.8) 1.0, 1.4 -1.35(74) .18 0.15 
 C5 1.2 (0.6) 1.0, 1.4 0.8 (0.6) 0.6, 1.0 -2.39(74) .02 0.27 
HCR-20 Risk-M Total 6.4 (2.4) 5.6, 7.3 5.2 (1.9) 4.6, 5.7 -2.46(74) .01 0.28 
START Strength Total 21.0 (4.8) 19.4, 22.8 22.1 (4.9) 19.4, 22.8 0.94(74) .34 0.11 
START Vulnerability 
(V) Total 
22.3 (6.6) 20.1, 24.4 22.8 (8.7) 20.4, 25.3 0.32(74) .75 0.04 
Emotional 
State (V) 
1.3 (0.5) 1.1, 1.4 1.5 (0.5) 1.3, 1.7 2.10(74) .04 0.24 
Attitudes (V) 1.4 (0.6) 1.2, 1.6 1.2 (0.7) 1.0, 1.4 -1.25(74) .21 0.15 
 Physical aggression only    
 Physical aggression 
(n=13) 
No physical aggression 
(n=63) 
   
NAS Total 101.1 
(15.8) 
92.7, 
110.0 
87.5 
(15.0) 
84.2, 91.2 -2.94(74) .00 0.32 
HCR-20 Clinical Total 7.8 (1.4) 7.0, 8.5 5.3 (2.3) 4.7, 5.8 -3.80(74) .00 0.40 
C1 1.8 (0.3) 1.5, 2.0 1.3 (0.6) 1.2, 1.5 -2.39(74) .02 0.27 
 C4 1.8 (0.4) 1.5, 2.0 1.2 (0.8) 1.0, 1.4 -2.53(74) .01 0.28 
 C5 1.2 (0.6) 0.9, 1.5 0.9 (0.6) 0.8, 1.1 -1.52(74) .13 0.17 
HCR-20 Risk-M Total 6.7 (2.2) 5.4, 7.9 5.5 (2.2) 5.0, 6.1 -1.72(74) .09 0.19 
START Strength Total 18.9 (3.2) 17.1, 20.7 22.2 (5.0) 20.4, 24.3 2.24(74) .03 0.25 
START Vulnerability 
(V) Total 
24.1 (6.4) 20.6, 28.0 22.3 (8.0) 20.4, 24.3 -0.76(74) .45 0.09 
Emotional 
State (V) 
1.4 (0.5) 1.1, 1.7 1.4 (0.6) 1.4, 1.6 0.16(74) .87 0.02 
Attitudes (V) 1.4 (0.7) 1.0, 1.7 1.3 (0.7) 1.1, 1.4 -0.64(74) .52 0.07 
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Table 3. Pearson’s r correlation between patients’ self-reported anger and SPJ dynamic risk items and subscales  
 1 2 3 4 5 6 7 8 9 NAS Total 
1 
HCR-20 Clinical Total 
 .80** 
[.69, .87] 
.58** 
[.41, .72] 
.71** 
[.62, .81] 
.45** 
[.25, .63] 
-.53** 
[-.67, -.37] 
.43** 
[.22, .61] 
.22 
[.00, .41] 
.40** 
[.21, .57] 
.46** 
[.32, .60] 
2 
HCR-20 C1 
  .39** 
[.16, .57] 
.57** 
[.41, .69] 
.43** 
[.21, .62] 
-.37 
[-.56, -.15] 
.37** 
[.14, .55] 
.24* 
[.04, .42] 
.31** 
[.10, .49] 
37** 
[.18, .55] 
3 
HCR-20 C4 
   .29* 
[.07, .50] 
.30** 
[.10, .50] 
-.60** 
[-.73, -.44] 
.56** 
[.39, .70] 
.57** 
[.43, .70] 
.39** 
[.16, .62] 
.42** 
[.25, .58] 
4 
HCR-20 C5 
    .35** 
[.16, .53] 
-.34 
[-.56, -.11] 
.41** 
[.22, .58] 
.17 
[-.08, .37] 
.35** 
[.15, .56] 
.35** 
[.15, .52] 
5 
HCR-20 Risk-m Total 
     -.35** 
[-.53, -.18] 
-.37** 
[.17, .55] 
.23* 
[.03, .45] 
34** 
[.16, 52] 
.23* 
[-.04, .48] 
6 
START Strengths Total 
      -.66** 
[-.77, -.53] 
-.46** 
[-.61, -.29] 
-.49** 
[-.67, -.28] 
-.35** 
[-.52, -.17] 
7 
START Vulnerabilities 
(V) Total 
       .72** 
[.61, .81] 
.70** 
[.57, .80] 
.34** 
[.15, .53] 
8 
START Emotional state 
(V) 
        .49** 
[.32, .65] 
.29* 
[.07, .47] 
9 START Attitude (V)          .29* 
[.08, .48] 
*p<.05 **p<.01 [95% Confidence Interval] 
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Table 4. Predictive validity of the scales for any inpatient aggression, and physical aggression only 
 
 
Any aggression Physical Aggression only 
AUC p 95% CI Sensi-
tivity 
Speci-
ficity 
AUC p 95% CI Sensi-
tivity 
Speci-
ficity 
NAS Total .64* .04 .51, .77 0.64 0.33 .75** .01 .60, .89 0.85 0.40 
HCR-20 Clinical 
Total 
.72** .01 .61, .84 0.74 0.33 .81** .00 .71, .92 1.00 0.41 
HCR-20 Risk-M 
Total 
.63* .05 .50, .76 0.62 0.43 .66 .07 .48, .84 0.69 0.48 
START 
Strengths Total 
.56 .34 .43, .69 0.41 0.50 .69** .01 .54, .83 0.31 0.49 
START 
Vulnerabilities 
Total 
.46 .58 .33, .59 0.47 0.50 .56 .52 .40, .71 0.46 0.54 
AUC, area under receiver operating characteristic curve; CI, confidence interval 
n = 76 
*p<.05 **p<.01 
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Table 5. Logistic regression models for incremental predictive 
validity of patients’ self-reported anger in aggressive outcomes 
using significant variables from ROC analyses 
 B [95% CI] OR (95% CI) 
Any aggression 
Constanta -2.89   
HCR-20 Clinical 
Total 
0.32** [-0.14, 0.72] 1.38 (1.07, 1.77) 
HCR-20 Risk-M 
Total 
0.13 [-0.11, 0.44] 1.15 (0.89, 1.47) 
 
Constantb -3.33  
HCR-20 Clinical 
Total 
0.30* [0.01, 0.74] 1.35 (1.02, 1.77) 
HCR-20 Risk-M 
Total 
0.13 [-0.21, 0.44] 1.14 (0.89, 1.47) 
NAS Total 0.01 [-0.03, 0.05] 1.00 (0.97, 1.04) 
Physical aggression only 
Constanta -4.45  
HCR-20 Clinical 
Total 
0.59** [0.24, 1.24] 1.82 (1.17, 2.82) 
START Strength 
Total 
-0.05 [-0.34, 0.15] 0.94 (0.78, 1.14) 
Constantb -6.88  
HCR-20 Clinical 
Total 
0.52** [0.18, 1.18] 1.69 (1.07, 2.67) 
START Strength 
Total 
-0.05 [-0.32, 0.24] 0.95 (0.78, 1.16) 
NAS Total 0.03 [-0.03, 0.10] 1.02 (0.98, 1.07) 
*p<.05 **p<.01, n = 76 
Any aggression: 
aNote. R²= .16 (Cox & Snell) .21 (Nagelkerke). Model χ ²(1) = 12.88 p<.01 
bNote. R²= .16 (Cox & Snell) .21 (Nagelkerke). Model χ ²(2) = 13.00 p<.01 
Note. χ ²(2) - χ ²(1) = 0.12 p>.05 
Physical aggression only: 
aNote. R²= .18 (Cox & Snell) .30 (Nagelkerke). Model χ ²(1) = 15.15 p<.01 
bNote. R²= .20 (Cox & Snell) .33 (Nagelkerke). Model χ ²(2) = 16.81 p<.01 
Note. χ ²(2) - χ ²(1) = 1. 66 p>.05 
 
 
 
